Keating Financial Advisory Services’s InflaRx IFRX Stock Holding History

Keating Financial Advisory Services’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$600	Hold	671	–	–	﹤0.01%	2224
2025 Q4	$678	Buy	+671	New	+$833	﹤0.01%	1898

Other funds holding IFRX

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

T3 Companies New York $76.8M AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Keating Financial Advisory Services's IFRX Position: Q1 2026 in Review

Keating Financial Advisory Services held its InflaRx (IFRX) position steady in Q1 2026 at 671 shares worth $600. The position accounts for ﹤0.01% of the portfolio, ranked #2224.

Keating Financial Advisory Services first reported a position in IFRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $678 in Q4 2025. 35 funds tracked by Wall St. Rank hold IFRX as of Q1 2026.

Keating Financial Advisory Services held 671 shares of InflaRx worth $600 as of Q1 2026.
Keating Financial Advisory Services left its InflaRx share count unchanged in Q1 2026.
InflaRx made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q1 2026, its #2224 holding.
Keating Financial Advisory Services first reported a position in InflaRx in Q4 2025 and has held it in 2 quarters since.
Keating Financial Advisory Services's InflaRx position peaked at $678 in Q4 2025.
35 funds tracked by Wall St. Rank held InflaRx as of Q1 2026.

Based on Keating Financial Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.